NASDAQ:GALT
$1.57
(
-1.26%
)
Friday, 2nd Jun 2023
Galectin Therapeutics Inc. Stock Price (Quote)
| Range | Low Price | High Price | Comment |
|---|---|---|---|
| 30 days | $1.52 | $1.93 | Friday, 2nd Jun 2023 GALT stock ended at $1.57. This is 1.26% less than the trading day before Thursday, 1st Jun 2023. During the day the stock fluctuated 5.96% from a day low at $1.56 to a day high of $1.65. |
| 90 days | $1.52 | $2.40 | |
| 52 weeks | $1.02 | $2.57 |
Historical Galectin Therapeutics Inc. prices
| Date | Open | High | Low | Close | Volume |
| 2023-06-02 | $1.65 | $1.65 | $1.56 | $1.57 | 21 050 |
| 2023-06-01 | $1.60 | $1.65 | $1.57 | $1.59 | 28 926 |
| 2023-05-31 | $1.66 | $1.69 | $1.52 | $1.57 | 130 421 |
| 2023-05-30 | $1.59 | $1.74 | $1.59 | $1.61 | 25 747 |
| 2023-05-26 | $1.61 | $1.75 | $1.60 | $1.60 | 81 438 |
| 2023-05-25 | $1.80 | $1.85 | $1.65 | $1.65 | 64 949 |
| 2023-05-24 | $1.77 | $1.82 | $1.76 | $1.78 | 16 611 |
| 2023-05-23 | $1.79 | $1.91 | $1.78 | $1.80 | 63 578 |
| 2023-05-22 | $1.73 | $1.87 | $1.71 | $1.82 | 45 977 |
| 2023-05-19 | $1.62 | $1.79 | $1.62 | $1.75 | 40 646 |
| 2023-05-18 | $1.67 | $1.70 | $1.64 | $1.65 | 29 181 |
| 2023-05-17 | $1.63 | $1.68 | $1.62 | $1.67 | 70 400 |
| 2023-05-16 | $1.66 | $1.72 | $1.62 | $1.62 | 33 352 |
| 2023-05-15 | $1.75 | $1.75 | $1.64 | $1.64 | 57 597 |
| 2023-05-12 | $1.73 | $1.80 | $1.69 | $1.69 | 29 420 |
| 2023-05-11 | $1.77 | $1.81 | $1.74 | $1.76 | 36 871 |
| 2023-05-10 | $1.76 | $1.83 | $1.75 | $1.81 | 23 742 |
| 2023-05-09 | $1.85 | $1.85 | $1.72 | $1.77 | 31 522 |
| 2023-05-08 | $1.71 | $1.93 | $1.71 | $1.88 | 91 421 |
| 2023-05-05 | $1.68 | $1.76 | $1.66 | $1.72 | 30 498 |
| 2023-05-04 | $1.65 | $1.68 | $1.64 | $1.65 | 25 626 |
| 2023-05-03 | $1.71 | $1.77 | $1.68 | $1.68 | 32 273 |
| 2023-05-02 | $1.77 | $1.83 | $1.62 | $1.66 | 53 356 |
| 2023-05-01 | $1.77 | $1.84 | $1.71 | $1.71 | 26 277 |
| 2023-04-28 | $1.70 | $1.76 | $1.71 | $1.76 | 42 319 |
| 2023-04-27 | $1.75 | $1.77 | $1.71 | $1.74 | 65 493 |
| 2023-04-26 | $1.76 | $1.83 | $1.75 | $1.76 | 31 606 |
| 2023-04-25 | $1.85 | $1.86 | $1.75 | $1.75 | 58 882 |
| 2023-04-24 | $1.92 | $1.94 | $1.84 | $1.84 | 35 866 |
| 2023-04-21 | $1.94 | $1.98 | $1.91 | $1.92 | 40 844 |
| 2023-04-20 | $2.04 | $2.04 | $1.92 | $1.98 | 55 576 |
| 2023-04-19 | $1.97 | $2.05 | $1.96 | $2.04 | 60 113 |
| 2023-04-18 | $2.05 | $2.05 | $1.98 | $1.98 | 50 248 |
| 2023-04-17 | $1.99 | $2.04 | $1.96 | $2.03 | 80 029 |
| 2023-04-14 | $2.09 | $2.10 | $1.97 | $2.01 | 37 436 |
| 2023-04-13 | $2.01 | $2.08 | $2.01 | $2.04 | 38 484 |
| 2023-04-12 | $2.03 | $2.10 | $1.98 | $2.04 | 56 161 |
| 2023-04-11 | $1.97 | $2.09 | $1.97 | $2.04 | 49 562 |
| 2023-04-10 | $2.06 | $2.11 | $2.00 | $2.02 | 54 398 |
| 2023-04-06 | $2.01 | $2.10 | $2.01 | $2.08 | 32 656 |
| 2023-04-05 | $1.96 | $2.01 | $1.95 | $2.01 | 19 944 |
| 2023-04-04 | $1.91 | $2.02 | $1.91 | $1.96 | 53 747 |
| 2023-04-03 | $2.07 | $2.09 | $1.92 | $1.94 | 84 991 |
| 2023-03-31 | $2.26 | $2.26 | $2.06 | $2.10 | 45 249 |
| 2023-03-30 | $2.06 | $2.20 | $2.05 | $2.17 | 102 967 |
| 2023-03-29 | $2.03 | $2.10 | $1.95 | $2.06 | 73 009 |
| 2023-03-28 | $1.93 | $1.99 | $1.91 | $1.99 | 25 390 |
| 2023-03-27 | $1.95 | $1.99 | $1.92 | $1.95 | 43 968 |
| 2023-03-24 | $1.94 | $1.98 | $1.90 | $1.96 | 32 600 |
| 2023-03-23 | $1.99 | $2.00 | $1.90 | $1.98 | 21 420 |
About Galectin Therapeutics Inc.
Galectin Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the research and development of therapies for fibrotic, cancer, and other diseases. The company's lead product candidate is belapectin (GR-MD-02) galectin-3 inhibitor, a galactoarabino-rhamnogalacturonan polysaccharide polymer that is in Phase III clinical trial for the treatment of liver fibrosis associated with fatty liver disease and non-alcoholic steatohepatiti... GALT Profile
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
